Raju Kandimalla

4PUBLICATIONS
39CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsEpidemiological methodsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 11, 2025
Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer.

Surendra Nayak, John D Norris, Massimo Ammirante

|Sep 01, 2021
EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers.

Raju Kandimalla, Jianfeng Xu, Alexander Link

|May 26, 2021
OCaMIR-A Noninvasive, Diagnostic Signature for Early-Stage Ovarian Cancer: A Multi-cohort Retrospective and Prospective Study.

Raju Kandimalla, Wei Wang, Fan Yu

|Apr 03, 2020
A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma.

Raju Kandimalla, Hideo Tomihara, Jasjit K Banwait

Pageof 1